Clinical Trials Browser

Phase 2 × OTHER × Advanced Pancreatic Carcinoma × Clear all

NCT05257122 2022-02-25

A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer

Phase 2 Unknown

Gastrointestinal

Advanced Pancreatic Carcinoma